Skip to main content
Home/Peptides/TB-500
HEALING PEPTIDE
FDA-Approved

TB-500

Thymosin Beta-4 (TB-500)

Systemic cell-migration and tissue-repair peptide, most commonly stacked with BPC-157 for the "Wolverine" recovery protocol.

Regulatory status last verified 2026-04-24
FDA STATUS
Not FDA-approved
HALF-LIFE
~hours systemic; localized effects persist longer
ROUTE
Subcutaneous or intramuscular
CLASSIFICATION
Synthetic 17-amino-acid actin-binding peptide
AMINO ACID SEQUENCE

43 residues· First described 1981

Hydrophobic
Polar
Acidic (-)
Basic (+)

Active fragment of Thymosin Beta-4 (43-residue full protein)

USED IN PROTOCOLS FOR
Recover FasterSkin & Aesthetics

Overview

TB-500 is a synthetic analog of Thymosin Beta-4, a naturally occurring actin-sequestering protein that plays a central role in cell migration, angiogenesis, and wound healing. While BPC-157 drives angiogenesis and gut-mucosal repair, TB-500 handles cellular migration across tissues - which is why they're often stacked ("Wolverine Stack") for synergistic effect on connective-tissue injuries that neither compound alone resolves as quickly.

TB-500 is particularly useful in injuries where the damage is systemic or spans multiple structures - post-surgical rehab, chronic tendinopathy, multi-joint overuse. Its long systemic effect profile makes it injectable less frequently than BPC-157 (typically 2× weekly during loading, dropping to weekly after).

Because the primary signal is functional (pain, ROM, return-to-sport) rather than a single moving biomarker, tracking TB-500 requires protocol discipline - dose dates logged, pain/ROM tracked in parallel, and hs-CRP as the systemic inflammation read-through.

Mechanism of Action

TB-500 sequesters actin monomers in the cytoplasm, which liberates cells to migrate to sites of injury. It upregulates VEGF, stimulates endothelial cell proliferation and differentiation, and accelerates conversion of myoblasts to muscle fiber. Effects are broadly distributed via the circulatory system rather than localized to injection site, unlike BPC-157's stronger local signal.

Community Usage Patterns

Loading protocol: 2–2.5 mg SC or IM, 2× per week for 4–6 weeks. Maintenance: 1–2 mg once weekly. Most protocols continue for 8–16 weeks depending on injury. Stacks extremely well with BPC-157 500 mcg daily for soft-tissue injury. Injection can be abdomen, glute, or near injury site - site matters less than with BPC-157 because the effect is systemic.

Education only - not medical advice. Any protocol change should involve your licensed provider.

Biomarkers to Track

When running TB-500, these are the biomarkers most commonly tracked to assess response and safety:

hs-CRPCBC with differentialFerritinSerum copper (if stacked with GHK-Cu)

Reconstitution Calculator

Free calculator for TB-500 reconstitution math - vial size, BAC water volume, and exact syringe units.

Open TB-500 calculator →

Side Effects & Monitoring

What TB-500 side effects are commonly reported, when they appear, the red flags worth a provider call, and the biomarkers that catch issues early.

TB-500 side effects & what to track →

Results & What to Track

What TB-500 results actually look like in the data - the markers to measure, when they tend to move, and how to tell a real result from placebo.

TB-500 results & how to measure them →

Related Reading

Related Peptides

BPC-157
Healing
GHK-Cu
Cosmetic

Stacks That Include TB-500

RECOVERY STACK
Wolverine Recovery Stack
The most-researched soft-tissue repair combination - BPC-157 anchored with TB-500 for systemic cellular migration.
RECOVERY STACK
Injury Rehabilitation Stack
BPC-157 + TB-500 + Thymosin Beta-4 - the expanded tissue-repair combination for post-surgical and chronic-injury research.

TB-500 Head-to-Head Comparisons

BPC-157 vs TB-500
Users researching soft-tissue injury protocols, post-surgical recovery, or chronic tendinopathy.

Conditions TB-500 is Commonly Researched For

Informational only - TB-500 is not presented as a treatment for any condition below. These are contexts in which users research the compound and discuss it with their licensed provider.
INFLAMMATION
Chronic Low-Grade Inflammation
The persistent low-level inflammatory pattern linked to cardiovascular, metabolic, and cognitive disease - trackable via specific markers.
RECOVERY
Poor Recovery / Overtraining
The pattern users see when training load exceeds recovery capacity - trackable via HRV, RHR, and specific biomarkers.
Track TB-500 against your labs.

Log doses, upload your lab PDFs, and let StackAI read your panel in context of what you're actually running. Free to start.

Start tracking →

This page is informational and does not constitute medical advice. MyProtocolStack is a tracking and education platform. Work with a licensed provider before starting, changing, or stopping any protocol.